Medimaps Group
The company develops deep-tech and AI imaging software to assess bone microarchitecture and predict fracture risk in patients with osteoporosis. Its primary product, TBS Osteo, integrates with DXA bone densitometry scans to provide clinical insights for healthcare professionals. The technology is used by clinicians and researchers in over 90 countries to identify patients at risk of fracture who may be missed by standard bone density tests.
Visit websitePlan-les-Ouates, Switzerland
Healthtech
Medical Devices
Artificial Intelligence
Diagnostics
Funding summary
- Total raised
- €17.7M
- Funding rounds
- 1
Investors in Medimaps Group
Investors on record for Medimaps Group. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Medimaps Group?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors